½ÃÀ庸°í¼­
»óǰÄÚµå
1461271

¼¼°èÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå(2024-2034³â)

Female Health Tech Market Report 2024-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Visiongain | ÆäÀÌÁö Á¤º¸: ¿µ¹® 284 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿©¼º Çコ Å×Å© ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö ¿¬Æò±Õ 9.6%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¿©¼ºÀÇ °Ç°­¿¡ ´ëÇÑ Àνİú °ü½É Áõ°¡:

¿À·§µ¿¾È °£°úµÇ¾î ¿Ô´ø ¿©¼º ƯÀ¯ÀÇ °Ç°­°ü¸® ¿ä±¸°¡ ÁÖ¸ñ¹Þ±â ½ÃÀÛÇϸ鼭 ¿©¼º °Ç°­¿¡ ´ëÇÑ Àνİú ÃÊÁ¡ÀÌ ¹Ù²î°í ÀÖ½À´Ï´Ù. ¿©¼ºÀÇ °Ç°­ ¹®Á¦´Â Á¾Á¾ °£°úµÇ°Å³ª ÀÇ·á¶ó´Â ³ÐÀº ¸Æ¶ô¿¡¼­ ÀϹÝÈ­µÇ¾î ¿ÔÁö¸¸, ÀÇ·á Àü¹®°¡, ¿¬±¸ÀÚ, ¿ËÈ£ ´Üü, Á¤Ã¥ ÀÔ¾ÈÀÚµéÀÇ ´ÜÇÕµÈ ³ë·ÂÀ¸·Î ÀÌ·¯ÇÑ »óȲÀÌ Å©°Ô ¹Ù²î°í ÀÖ½À´Ï´Ù. ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê´Â ¿©¼º ƯÀ¯ÀÇ »óŸ¦ ޱ¸ÇÏ°í »ý½Ä °Ç°­, È£¸£¸ó º¯µ¿, Àڱ󻸷Áõ ¹× ´Ù³¶¼º ³­¼Ò ÁõÈıº(PCOS)°ú °°Àº Áúº´ÀÇ º¹À⼺À» ¹àÇô³»´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ ±³À° Ä·ÆäÀÎÀº ¿©¼º °Ç°­À» µÑ·¯½Ñ ±Ý±â¸¦ ¾ø¾Ö°í, ¿­¸° ´ëÈ­¸¦ ÃËÁøÇϸç, ¿©¼ºµéÀÌ ÀÚ½ÅÀÇ ÇູÀ» ¿ËÈ£ÇÒ ¼ö ÀÖµµ·Ï ÈûÀ» ½Ç¾îÁÖ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. °øÁߺ¸°Ç Ä·ÆäÀÎÀº »ê¸ð »ç¸Á·ü, À¯¹æ¾Ï ÀνÄ, ÇÇÀÓ Á¢±Ù¼º µî Áß¿äÇÑ À̽´¸¦ ÁýÁß Á¶¸íÇÏ¿© Ç¥ÀûÈ­µÈ °³ÀÔÀÇ ½Ã±Þ¼ºÀ» °­Á¶ÇØ ¿Ô½À´Ï´Ù. ¶ÇÇÑ, ¿ËÈ£ ¿îµ¿Àº Á¤Ã¥ º¯È­¸¦ Ã˱¸ÇÏ°í ¿©¼º °Ç°­ÀÌ °øÁߺ¸°Ç ¹®Á¦ÀÇ ±âº»Àû Ãø¸éÀ̶ó´Â ÀνÄÀ» Á¦°íÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎ½Ä Áõ°¡´Â ÇコÄɾ ´ëÇÑ º¸´Ù Á¾ÇÕÀûÀÎ Á¢±ÙÀ» ÃËÁøÇßÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¿ù°æ ÃßÀû¿ë ¿þ¾î·¯ºí ±â±âºÎÅÍ °³ÀÎÈ­µÈ °Ç°­ ÅëÂû·ÂÀ» À§ÇÑ AI ±â¹Ý Ç÷§Æû¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¼Ö·ç¼ÇÀ¸·Î ¿©¼º Çコ Å×Å©ÀÇ Çõ½ÅÀ» ÃËÁøÇß½À´Ï´Ù. Çõ½ÅÀ» ÁÖµµÇß½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¿©¼º °Ç°­¿¡ ´ëÇÑ Àνİú °ü½É Áõ°¡´Â °øÆòÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ´ëÇÑ ¸Å¿ì Áß¿äÇÑ º¯È­À̸ç, ¿©¼ºÀÇ ´Ù¾çÇÑ »ý¾ÖÁֱ⿡ µû¸¥ ´Ù¾çÇÑ ¿ä±¸»çÇ׿¡ ´ëÇÑ ±íÀº ÀÌÇØ¸¦ ÀǹÌÇÕ´Ï´Ù.

ȯÀÚ Ä¡·áÀÇ ±â¼ú ¹ßÀü :

¿©¼º °Ç°­ ±â¼ú ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº ¿©¼º ƯÀ¯ÀÇ ¿ä±¸¿Í °æÇè¿¡ ¸Â°Ô Á¶Á¤µÈ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ¿©¼º °Ç°­ °ü¸®ÀÇ »óȲÀ» ¹Ù²Ù¾î ³õ¾Ò½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº »ý½Ä °Ç°­¿¡¼­ °»³â±â °ü¸®±îÁö ´Ù¾çÇÑ ºÐ¾ß¿¡ °ÉÃÄ ´Ù¾çÇÑ ±â¼ú ºÐ¾ßÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î °¡´ÉÇß½À´Ï´Ù.

½º¸¶Æ®¿öÄ¡¿Í ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í °°Àº ¿þ¾î·¯ºí ±â±â´Â ¿©¼ºµéÀÌ »ý¸® Áֱ⸦ ¸ð´ÏÅ͸µÇÏ°í °¡ÀÓ ±â°£À» ÃßÀûÇϸç Àü¹ÝÀûÀÎ °Ç°­°ú À£ºùÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â °­·ÂÇÑ µµ±¸·Î µîÀåÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ¼¾¼­¿Í ¾Ë°í¸®ÁòÀ» Ȱ¿ëÇÏ¿© »ý¸®Àû ¸Å°³º¯¼ö µ¥ÀÌÅ͸¦ ¼öÁýÇÏ¿© »ç¿ëÀÚ¿¡°Ô »ý½Ä °Ç°­¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇϰí ÇÇÀÓ, Àӽаèȹ ¹× »ý¸®Áֱ⠰ü¸®¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀÌ¼Ç ¶ÇÇÑ ¿©¼ºµéÀÌ ÀÚ½ÅÀÇ °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÛÀº »ý¸® ÃßÀû, ¹è¶õ ¿¹Ãø, ÀӽЏð´ÏÅ͸µ, Àڱ󻸷Áõ ¹× Àڱ󻸷Áõ°ú °°Àº Áõ»ó °ü¸® µî ´Ù¾çÇÑ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¾ÛÀº °Ç°­ Á¤º¸¸¦ µðÁöÅÐÈ­ÇÏ°í °³ÀÎÈ­µÈ ÃßõÀ» Á¦°øÇÔÀ¸·Î½á ¿©¼ºµéÀÌ ÀÚ½ÅÀÇ °Ç°­°ú À£ºùÀ» °ü¸®ÇÏ´Â µ¥ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¿ø°Ý ÀÇ·á Ç÷§ÆûÀº ƯÈ÷ ÀÇ·á ÇýÅÃÀÌ ºÎÁ·ÇÑ Áö¿ªÀ̳ª À̵¿¿¡ Á¦¾àÀÌ ÀÖ´Â ¿©¼ºµéÀÇ ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ» È®´ëÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ ¿ø°Ý »ó´ãÀ» ¿ëÀÌÇÏ°Ô Çϰí, ¿©¼ºµéÀÌ Áý¿¡ ÀÖÀ¸¸é¼­ Á¶¾ðÀ» ±¸Çϰí, Áø´ÜÀ» ¹Þ°í, Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ´Â ´ë¸é ÀÇ·á ¼­ºñ½º°¡ Á¦ÇÑÀûÀ̾ú´ø Äڷγª19 »çÅ¿¡¼­ ƯÈ÷ ±× °¡Ä¡°¡ ÀÔÁõµÇ¾ú½À´Ï´Ù.

¼¼°è ¿©¼º¿ë ÇコÅ×Å©(Women's Health Tech) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢ ºÎ¹®º°/Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå º¸°í¼­ °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • COVID-19ÀÇ ¿µÇ⠺м®
  • PorterÀÇ Five Forces ºÐ¼®
  • PEST ºÐ¼®

Á¦4Àå ¿©¼º Çコ Å×Å© ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö
  • ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø
  • ¼ÒºñÀÚ Á¦Ç°
  • µð¹ÙÀ̽º(¿þ¾î·¯ºí, Çϵå¿þ¾î)
  • ¼ÒÇÁÆ®¿þ¾î(¾Û)
  • Áø´Ü
  • µðÁöÅÐ Ç÷§Æû
  • ÀǾàǰ/ºñŸ¹Î/º¸ÃæÁ¦
  • ¼­ºñ½º
  • ¿ø°ÝÀÇ·á
    • ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² : Áö¿ªº°

Á¦5Àå ¿©¼º Çコ Å×Å© ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö
  • ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø
  • ÀӽŠ¹× °£È£
  • »ý½Ä º¸°Ç ¹× ÇÇÀÓ
  • ¿ù°æ °Ç°­
  • ÀÏ¹Ý °Ç°­
  • °ñ¹Ý ¹× Àڱà °Ç°­
  • ¼º °Ç°­
  • ¿©¼º À£´Ï½º
  • °»³â±â Äɾî
  • Àå¼ö
  • Á¤½Å°Ç°­
    • ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² : Áö¿ªº°

Á¦6Àå ¿©¼º Çコ Å×Å© ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø

Á¦7Àå ºÏ¹ÌÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå ºÐ¼®

Á¦8Àå À¯·´ÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå ºÐ¼®

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå ºÐ¼®

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå ºÐ¼®

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿©¼º Çコ Å×Å© ½ÃÀå ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • °æÀï ±¸µµ
  • Àü·«Àû Àü¸Á
  • Athena Feminine Technologies, Inc.
  • Bloomlife, Inc.
  • Elvie(Chiaro Technology Limited)
  • HeraMed Ltd
  • iSono Health, Inc.
  • Minerva Surgical, Inc.
  • Nuvo, Inc.
  • Prelude Fertility, Inc.
  • Sera Prognostics
  • Univfy, Inc.
  • Totohealth Limited

Á¦13Àå °á·Ð ¹× Á¦¾È

  • VisiongainÀÇ °á·Ð
  • Ãßõ »çÇ×
LSH 24.04.30

The global Female Health Tech market is estimated to grow at a CAGR of 9.6% by 2034

The Female Health Tech Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increased Awareness and Focus on Women's Health

Increased awareness and focus on women's health have been transformative, driven by a confluence of factors that have brought long-overdue attention to the unique healthcare needs of women. Historically, women's health issues were often overlooked or generalized within the broader context of healthcare. However, concerted efforts from healthcare professionals, researchers, advocacy groups, and policymakers have reshaped this landscape. Research initiatives have delved into conditions specific to women, unravelling the complexities of reproductive health, hormonal fluctuations, and diseases like endometriosis and polycystic ovary syndrome (PCOS). Simultaneously, educational campaigns have sought to dismantle taboos surrounding women's health, fostering open dialogues and empowering women to advocate for their own well-being. Public health campaigns have spotlighted critical issues such as maternal mortality rates, breast cancer awareness, and access to contraception, amplifying the urgency for targeted interventions. Moreover, advocacy movements have catalyzed policy changes, leading to greater recognition of women's health as a fundamental aspect of public health agendas. This heightened awareness has not only fostered a more inclusive approach to healthcare but has also driven innovation in female health technology, with solutions ranging from wearable devices for menstrual tracking to AI-powered platforms for personalized health insights. Overall, the increased awareness and focus on women's health signify a pivotal shift towards equitable healthcare provision and a deeper understanding of the diverse needs of women across the lifespan.

Technological advancements in patient care

Technological advancements in female health tech have revolutionized the landscape of women's healthcare, offering innovative solutions tailored to address the unique needs and experiences of women. These advancements span a wide range of areas, from reproductive health to menopause management, and have been made possible by breakthroughs in various fields of technology.

Wearable devices, such as smartwatches and fitness trackers, have emerged as powerful tools for women to monitor their menstrual cycles, track fertility windows, and manage overall health and wellness. These devices leverage sensors and algorithms to collect data on physiological parameters, providing users with valuable insights into their reproductive health and helping them make informed decisions about contraception, fertility planning, and menstrual cycle management.

Mobile applications have also played a crucial role in empowering women to take control of their health. These apps offer a diverse array of features, including menstrual tracking, ovulation prediction, pregnancy monitoring, and symptom management for conditions like endometriosis and PCOS. By digitizing health information and providing personalized recommendations, these apps enable women to actively participate in managing their health and well-being.

Telemedicine platforms have expanded access to healthcare services for women, particularly in underserved areas or for individuals with mobility constraints. These platforms facilitate remote consultations with healthcare providers, enabling women to seek advice, receive diagnoses, and access treatments from the comfort of their homes. This has proven especially valuable during the COVID-19 pandemic, when in-person healthcare services were limited.

What Questions Should You Ask before Buying a Market Research Report?

How is the Female Health Tech Market evolving?

What is driving and restraining the Female Health Tech Market?

How will each Female Health Tech submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Female Health Tech submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Female Health Tech Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Female Health Tech projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Female Health

Tech projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Female Health Tech Market?

Where is the Female Health Tech Market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Female Health Tech Market today, and over the next 10 years:

Our 284-page report provides 101 tables and 130 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Female Health Tech Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Female Health Tech prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

By Product Types

Consumer Products

Devices (Wearables, Hardware)

Software (Apps)

Diagnostics

Digital Platform

Drugs, Vitamins & Supplements

Services

Telehealth

By Application

Pregnancy and Nursing Care

Reproductive Health and Contraception

Menstrual Health

General Healthcare

Pelvic and Uterine Healthcare

Sexual Health

Women's Wellness

Menopause Care

Longevity

Mental Health

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 25 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Poland

Belgium

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Singapore

Taiwan

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Female Health Tech Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Athena Feminine Technologies

Bloomlife

Elvie (Chiaro Technology Limited)

HeraMED

iSono Health

Minerva Surgical

NUVO Inc

Prelude Fertility, Inc.

Sera Prognostics

Univfy Inc.

TOTOHEALTH LIMITED

Overall world revenue for Female Health Tech Market, 2024 to 2034 in terms of value the market will surpass US$ 140.9 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Female Health Tech Market, 2024 to 2034 report help you?

In summary, our 280+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Female Health Tech Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 27 key national markets - See forecasts for the Female Health Tech Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 11 of the major companies involved in the Female Health Tech Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Female Health Tech Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Female Health Tech Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Awareness and Education
      • 3.2.1.2 Rapid Advancements in Technology are Catalysing the Growth of the Female Health Tech Market
      • 3.2.1.3 Increasing Empowerment and Advocacy for Women's Health and Wellness
      • 3.2.1.4 Healthcare Personalization is a Key Driving Force Behind the Growth of the Female Health Tech
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Complex Regulatory Frameworks and Varying Standards for Healthcare Technologies Across Different Region
      • 3.2.2.2 Privacy and Security Risks Associated with the Collection, Storage, and Transmission of Sensitive Health Data
      • 3.2.2.3 Healthcare Inequities and Disparities in Access to Healthcare Services, Particularly in Underserved Regions and Marginalized Communities
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Development of New Products and Services that Address Unmet Needs in Women's Health
      • 3.2.3.2 Partnerships Between Healthcare Providers, Technology Companies, and Research Institutions
      • 3.2.3.3 Global Health Initiatives Aimed at Improving Women's Health Outcomes
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Female Health Tech Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Application Segment: Market Attractiveness Index
  • 4.3 Female Health Tech Market Size Estimation and Forecast by Product Types
  • 4.4 Consumer Products
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Devices (Wearables, hardware)
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Software (Apps)
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Diagnostics
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Digital Platform
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Drugs, Vitamins & Supplements
    • 4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Services
    • 4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11 Telehealth
    • 4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.2 Market Share by Region, 2024 & 2034 (%)

5 Female Health Tech Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Female Health Tech Market Size Estimation and Forecast by Application
  • 5.4 Pregnancy and Nursing Care
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Reproductive Health and Contraception
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Menstrual Health
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 General Healthcare
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Pelvic and Uterine Healthcare
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Sexual Health
    • 5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)
  • 5.10 Women's Wellness
    • 5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.10.2 Market Share by Region, 2024 & 2034 (%)
  • 5.11 Menopause Care
    • 5.11.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.11.2 Market Share by Region, 2024 & 2034 (%)
  • 5.12 Longevity
    • 5.12.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.12.2 Market Share by Region, 2024 & 2034 (%)
  • 5.13 Mental Health
    • 5.13.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.13.2 Market Share by Region, 2024 & 2034 (%)

6 Female Health Tech Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America Female Health Tech Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Female Health Tech Market Attractiveness Index
  • 7.3 North America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 7.4 North America Female Health Tech Market Size Estimation and Forecast by Country
  • 7.5 North America Female Health Tech Market Size Estimation and Forecast by Product Type
  • 7.6 North America Female Health Tech Market Size Estimation and Forecast by Application
  • 7.7 U.S. Female Health Tech Market Analysis
  • 7.8 Canada Female Health Tech Market Analysis

8 Europe Female Health Tech Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Female Health Tech Market Attractiveness Index
  • 8.3 Europe Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 Europe Female Health Tech Market Size Estimation and Forecast by Country
  • 8.5 Europe Female Health Tech Market Size Estimation and Forecast by Product Type
  • 8.6 Europe Female Health Tech Market Size Estimation and Forecast by Application
  • 8.7 Germany Female Health Tech Market Analysis
  • 8.8 France Female Health Tech Market Analysis
  • 8.9 UK Female Health Tech Market Analysis
  • 8.10 Italy Female Health Tech Market Analysis
  • 8.11 Spain Female Health Tech Market Analysis
  • 8.12 Russia Female Health Tech Market Analysis
  • 8.13 Poland Female Health Tech Market Analysis
  • 8.14 Belgium Female Health Tech Market Analysis
  • 8.15 Rest of Europe Female Health Tech Market Analysis

9 Asia Pacific Female Health Tech Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Female Health Tech Market Attractiveness Index
  • 9.3 Asia Pacific Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Product Type
  • 9.6 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Application
  • 9.7 Japan Female Health Tech Market Analysis
  • 9.8 China Female Health Tech Market Analysis
  • 9.9 India Female Health Tech Market Analysis
  • 9.10 Australia Female Health Tech Market Analysis
  • 9.11 South Korea Female Health Tech Market Analysis
  • 9.12 Singapore Female Health Tech Market Analysis
  • 9.13 Taiwan Female Health Tech Market Analysis
  • 9.14 Rest of Asia Pacific Female Health Tech Market Analysis

10 Latin America Female Health Tech Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Female Health Tech Market Attractiveness Index
  • 10.3 Latin America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Latin America Female Health Tech Market Size Estimation and Forecast by Country
  • 10.5 Latin America Female Health Tech Market Size Estimation and Forecast by Product Type
  • 10.6 Latin America Female Health Tech Market Size Estimation and Forecast by Application
  • 10.7 Brazil Female Health Tech Market Analysis
  • 10.8 Mexico Female Health Tech Market Analysis
  • 10.9 Argentina Female Health Tech Market Analysis
  • 10.10 Colombia Female Health Tech Market Analysis
  • 10.11 Rest of Latin America Female Health Tech Market Analysis

11 MEA Female Health Tech Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Female Health Tech Market Attractiveness Index
  • 11.3 MEA Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 MEA Female Health Tech Market Size Estimation and Forecast by Country
  • 11.5 MEA Female Health Tech Market Size Estimation and Forecast by Product Type
  • 11.6 MEA Female Health Tech Market Size Estimation and Forecast by Application
  • 11.7 GCC Female Health Tech Market Analysis
  • 11.8 South Africa Female Health Tech Market Analysis
  • 11.9 Rest of MEA Female Health Tech Market Analysis

12 Company Profiles

  • 12.1 Competitive Landscape, 2022
  • 12.2 Summary of all Strategic Outlook
  • 12.3 Athena Feminine Technologies, Inc.
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Product Benchmarking
    • 12.3.4 Strategic Outlook
  • 12.4 Bloomlife, Inc.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Product Benchmarking
    • 12.4.4 Strategic Outlook
  • 12.5 Elvie (Chiaro Technology Limited)
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Product Benchmarking
    • 12.5.4 Strategic Outlook
  • 12.6 HeraMed Ltd
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
      • 12.6.3.1 Net Revenue, 2018-2022
      • 12.6.3.2 R&D, 2017-2022
    • 12.6.4 Product Benchmarking
    • 12.6.5 Strategic Outlook
  • 12.7 iSono Health, Inc.
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Product Benchmarking
    • 12.7.4 Strategic Outlook
  • 12.8 Minerva Surgical, Inc.
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Financial Analysis
      • 12.8.3.1 Net Revenue, 2020-2022
      • 12.8.3.2 R&D, 2020-2022
    • 12.8.4 Product Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Nuvo, Inc.
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Product Benchmarking
    • 12.9.4 Strategic Outlook
  • 12.10 Prelude Fertility, Inc.
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Product Benchmarking
    • 12.10.4 Strategic Outlook
  • 12.11 Sera Prognostics
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Financial Analysis
      • 12.11.3.1 Net Revenue, 2017-2022
      • 12.11.3.2 R&D, 2017-2022
    • 12.11.4 Product Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Univfy, Inc.
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Product Benchmarking
    • 12.12.4 Strategic Outlook
  • 12.13 Totohealth Limited
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Product Benchmarking

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦